Supernus Pharmaceuticals
SUPN
SUPN
245 hedge funds and large institutions have $1.67B invested in Supernus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 85 increasing their positions, 89 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
245
Holders Change
+8
Holders Change %
+3.38%
% of All Funds
3.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
32
Increased
85
Reduced
89
Closed
21
Calls
$766K
Puts
$778K
Net Calls
-$12K
Net Calls Change
-$571K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$26.6M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$15.7M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.24M |
| 4 |
BlackRock
New York
|
+$5.87M |
| 5 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$5.79M |
Top Sellers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$16.4M |
| 2 |
AC
Armistice Capital
New York
|
-$12.8M |
| 3 |
IHAM
Integral Health Asset Management
New York
|
-$6.07M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$5.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.8M |
